Husam Albarmawi, PhD

Novo Nordisk Inc.

Poster(s):

• (184) Real-world healthcare resource utilization and costs among 100% Fee-For-Service Medicare beneficiaries with metabolic dysfunction-associated steatohepatitis
  Wednesday, October 29, 2025